• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于易损动脉粥样硬化斑块特征可视化的新型纳米探针。

Emerging nanoprobes for the features visualization of vulnerable atherosclerotic plaques.

作者信息

Wang Xin, Mu Dan, Liang Jing, Xin Ruijing, Zhang Yukun, Liu Renyuan, Yao Mei, Zhang Bing

机构信息

Department of Radiology The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China.

Medical Imaging Center Affiliated Drum Tower Hospital Medical School of Nanjing University Nanjing China.

出版信息

Smart Med. 2024 Dec 3;3(4):e20240033. doi: 10.1002/SMMD.20240033. eCollection 2024 Dec.

DOI:10.1002/SMMD.20240033
PMID:39776593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11669784/
Abstract

Atherosclerosis (AS) is a major cause of cardiovascular disease. In particular, the unpredictable rupture of vulnerable atherosclerotic plaques (VASPs) can cause serious cardiovascular events such as myocardial infarction, stroke, and even sudden death. Therefore, early evaluation of the vulnerability of atherosclerotic plaques is of great importance. However, clinical imaging techniques are only marginally useful in the presence of severe anatomical structural changes, making it difficult to evaluate plaque vulnerability at an early stage. With the development of molecular imaging and nanotechnology, specific nanoprobes constructed for the pathological features of VASPs have attracted much attention for their ability to visualize VASPs early and noninvasively at the cellular and molecular levels. Here, we outline the pathological features of VASPs, analyze the superiority and limitations of current clinical imaging techniques, introduce the rational design principles of nanoprobes, and systematically summarize the application of nanoprobes to visualize the features of VASPs at the cellular and molecular levels. In addition, we discussed the prospects and urgent challenges in this field, and we believe it will provide new ideas for the early and accurate diagnosis of cardiovascular diseases.

摘要

动脉粥样硬化(AS)是心血管疾病的主要病因。特别是,易损动脉粥样硬化斑块(VASPs)的不可预测破裂可导致严重的心血管事件,如心肌梗死、中风,甚至猝死。因此,早期评估动脉粥样硬化斑块的易损性至关重要。然而,临床成像技术在存在严重解剖结构变化时作用有限,难以在早期阶段评估斑块易损性。随着分子成像和纳米技术的发展,针对VASPs病理特征构建的特异性纳米探针因其能够在细胞和分子水平上早期且无创地可视化VASPs的能力而备受关注。在此,我们概述VASPs的病理特征,分析当前临床成像技术的优势和局限性,介绍纳米探针的合理设计原则,并系统总结纳米探针在细胞和分子水平上可视化VASPs特征的应用。此外,我们讨论了该领域的前景和紧迫挑战,我们相信这将为心血管疾病的早期准确诊断提供新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/382851151c08/SMMD-3-e20240033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/729e24510333/SMMD-3-e20240033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/82acdfa40bde/SMMD-3-e20240033-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/43833bf831a4/SMMD-3-e20240033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/92bd143fef7a/SMMD-3-e20240033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/e8cbebd04914/SMMD-3-e20240033-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/20990d014502/SMMD-3-e20240033-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/92529ad9b3c0/SMMD-3-e20240033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/4b00fba6d98a/SMMD-3-e20240033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/002109a1544f/SMMD-3-e20240033-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/ebdc48d38939/SMMD-3-e20240033-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/40d519bd4c8c/SMMD-3-e20240033-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/fe800026d00a/SMMD-3-e20240033-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/382851151c08/SMMD-3-e20240033-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/729e24510333/SMMD-3-e20240033-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/82acdfa40bde/SMMD-3-e20240033-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/43833bf831a4/SMMD-3-e20240033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/92bd143fef7a/SMMD-3-e20240033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/e8cbebd04914/SMMD-3-e20240033-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/20990d014502/SMMD-3-e20240033-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/92529ad9b3c0/SMMD-3-e20240033-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/4b00fba6d98a/SMMD-3-e20240033-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/002109a1544f/SMMD-3-e20240033-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/ebdc48d38939/SMMD-3-e20240033-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/40d519bd4c8c/SMMD-3-e20240033-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/fe800026d00a/SMMD-3-e20240033-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9901/11669784/382851151c08/SMMD-3-e20240033-g006.jpg

相似文献

1
Emerging nanoprobes for the features visualization of vulnerable atherosclerotic plaques.用于易损动脉粥样硬化斑块特征可视化的新型纳米探针。
Smart Med. 2024 Dec 3;3(4):e20240033. doi: 10.1002/SMMD.20240033. eCollection 2024 Dec.
2
Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques.用于激光诱导易损动脉粥样硬化斑块协同消退的骨桥蛋白靶向诊疗纳米探针
Acta Pharm Sin B. 2022 Apr;12(4):2014-2028. doi: 10.1016/j.apsb.2021.12.020. Epub 2021 Dec 31.
3
Targeting the Microenvironment of Vulnerable Atherosclerotic Plaques: An Emerging Diagnosis and Therapy Strategy for Atherosclerosis.靶向易损粥样硬化斑块的微环境:动脉粥样硬化的新兴诊断和治疗策略。
Adv Mater. 2022 Jul;34(29):e2110660. doi: 10.1002/adma.202110660. Epub 2022 May 29.
4
Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching.通过调控血管平滑肌细胞表型转换抑制易损性动脉粥样硬化斑块进展的精准治疗性纳米药物。
Theranostics. 2018 Jun 12;8(13):3693-3706. doi: 10.7150/thno.24364. eCollection 2018.
5
Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers.工程化分子纳米探针靶向早期动脉粥样硬化:精准的诊断工具和有前途的治疗载体。
Nanotheranostics. 2023 Apr 2;7(3):327-344. doi: 10.7150/ntno.82654. eCollection 2023.
6
PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.用放射性标记的膜联蛋白A5对易损动脉粥样硬化斑块中的细胞凋亡进行正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)成像。
Q J Nucl Med Mol Imaging. 2009 Feb;53(1):26-34.
7
Pet tracers for vulnerable plaque imaging.宠物示踪剂在易损斑块成像中的应用。
Ann Nucl Med. 2020 May;34(5):305-313. doi: 10.1007/s12149-020-01458-7. Epub 2020 Mar 20.
8
Where is the trace? Molecular imaging of vulnerable atherosclerotic plaques.踪迹何在?易损动脉粥样硬化斑块的分子成像
Semin Thromb Hemost. 2007 Mar;33(2):151-8. doi: 10.1055/s-2007-969028.
9
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.从易损斑块到易损患者:对新定义和风险评估策略的呼吁:第二部分。
Circulation. 2003 Oct 14;108(15):1772-8. doi: 10.1161/01.CIR.0000087481.55887.C9.
10
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Vivo with Osteopontin-Specific Upconversion Nanoprobes.利用骨桥蛋白特异性上转换纳米探针活体分子成像易损动脉粥样硬化斑块
ACS Nano. 2017 Feb 28;11(2):1816-1825. doi: 10.1021/acsnano.6b07842. Epub 2017 Jan 31.

本文引用的文献

1
Computed Tomography Angiography: Principles and Advances.计算机断层血管造影术:原理与进展。
Radiol Clin North Am. 2024 May;62(3):371-383. doi: 10.1016/j.rcl.2024.01.005. Epub 2024 Feb 28.
2
Intracellular and extracellular synergistic therapy for restoring macrophage functions via anti-CD47 antibody-conjugated bifunctional nanoparticles in atherosclerosis.通过抗CD47抗体偶联的双功能纳米颗粒进行细胞内和细胞外协同治疗以恢复动脉粥样硬化中巨噬细胞功能
Bioact Mater. 2024 Jan 5;34:326-337. doi: 10.1016/j.bioactmat.2023.12.024. eCollection 2024 Apr.
3
Coronary Artery Calcification: Current Concepts and Clinical Implications.
冠状动脉钙化:当前概念与临床意义。
Circulation. 2024 Jan 16;149(3):251-266. doi: 10.1161/CIRCULATIONAHA.123.065657.
4
Biomimetic nanomedicines for precise atherosclerosis theranostics.用于精准动脉粥样硬化诊疗的仿生纳米药物
Acta Pharm Sin B. 2023 Nov;13(11):4442-4460. doi: 10.1016/j.apsb.2022.11.014. Epub 2022 Nov 15.
5
Assessing Early Atherosclerosis by Detecting and Imaging of Hypochlorous Acid and Phosphorylation Using Fluorescence Nanoprobe.利用荧光纳米探针检测和成像次氯酸和磷酸化来评估早期动脉粥样硬化。
Adv Mater. 2023 Dec;35(52):e2307008. doi: 10.1002/adma.202307008. Epub 2023 Nov 27.
6
Nanomedicine for Diagnosis and Treatment of Atherosclerosis.纳米医学用于动脉粥样硬化的诊断和治疗。
Adv Sci (Weinh). 2023 Dec;10(36):e2304294. doi: 10.1002/advs.202304294. Epub 2023 Oct 28.
7
T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease.动脉粥样硬化中的 T 细胞:血管疾病发病机制中的关键因素。
Cells. 2023 Aug 26;12(17):2152. doi: 10.3390/cells12172152.
8
CVIT 2023 clinical expert consensus document on intravascular ultrasound.2023 年心血管血管内超声临床专家共识文件
Cardiovasc Interv Ther. 2024 Jan;39(1):1-14. doi: 10.1007/s12928-023-00957-4. Epub 2023 Sep 1.
9
Carotid massive intraplaque hemorrhage, lipid-rich necrotic core, and heavy circumferential calcification were associated with new ipsilateral ischemic cerebral lesions after carotid artery stenting: high-resolution magnetic resonance vessel wall imaging study.颈动脉斑块内大量出血、富含脂质的坏死核心以及严重的圆周钙化与颈动脉支架置入术后同侧新发缺血性脑损伤相关:高分辨率磁共振血管壁成像研究
Cardiovasc Diagn Ther. 2023 Apr 28;13(2):355-366. doi: 10.21037/cdt-22-543. Epub 2023 Mar 1.
10
Rational Design of a Double-Locked Photoacoustic Probe for Precise In Vivo Imaging of Cathepsin B in Atherosclerotic Plaques.双锁光敏声学探针的合理设计用于动脉粥样硬化斑块中组织蛋白酶 B 的精确体内成像。
J Am Chem Soc. 2023 Aug 16;145(32):17881-17891. doi: 10.1021/jacs.3c04981. Epub 2023 Aug 2.